Prediction of response to recombinant human erythropoietin (r-HuEPO/epoetin-alpha) therapy in cancer patients
- PMID: 7888686
Prediction of response to recombinant human erythropoietin (r-HuEPO/epoetin-alpha) therapy in cancer patients
Comment on
-
Prediction of response to erythropoietin treatment in chronic anemia of cancer.Blood. 1994 Aug 15;84(4):1056-63. Blood. 1994. PMID: 7741835 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
